Viemed Healthcare - Common Shares (VMD) closed at $9.13 on November 11, 2026, up 1.7% from the previous close, on volume of 178,068 shares (30-day average 222,626).
Data as of November 11, 2026.
Analysts Offer Insights on Healthcare Companies: Viemed Healthcare (VMD) and Universal Health (UHS)
TipRanks (Mon, 9-Nov 10:30 AM ET)
Viemed Healthcare Announces Third Quarter 2026 Financial Results
ACCESS Newswire (Wed, 4-Nov 5:00 PM ET)
Viemed Healthcare Announces Third Quarter 2026 Earnings Conference Call Details
ACCESS Newswire (Thu, 22-Oct 8:00 AM ET)
ACCESS Newswire (Thu, 24-Sep 6:30 PM ET)
Viemed Healthcare Inc is a provider of home medical equipment ("HME") and post-acute healthcare services in the United States, with a focus on respiratory, chronic care, and women's health products and services. The Company's primary service offerings focus on effective in-home treatment, with clinical practitioners providing therapy and counseling to patients in their homes using cutting-edge technology. The company generates the majority of its revenue from medical equipment rental, sales, and supply.
Viemed Healthcare - Common Shares trades on the NASDAQ stock market under the symbol VMD.
As of November 11, 2026, VMD stock price climbed to $9.13 with 178,068 million shares trading.
VMD has a beta of -0.37, meaning it tends to be less sensitive to market movements. VMD has a correlation of 0.02 to the broad based SPY ETF.
VMD has a market cap of $351.36 million. This is considered a Small Cap stock.
Last quarter Viemed Healthcare - Common Shares reported $81 million in Revenue and $.11 earnings per share. This fell short of revenue expectation by $-107,000 and missed earnings estimates by -$.01.
In the last 3 years, VMD traded as high as $12.61 and as low as $5.93.
The top ETF exchange traded funds that VMD belongs to (by Net Assets): VTI, IWM, VXF, IWO, FSMD.
VMD has outperformed the market in the last year with a return of +42.9%, while the SPY ETF gained +12.6%. However, in the most recent history, VMD shares have underperformed the stock market with its stock returning -2.0% in the last 3 month period and -5.7% for the last 2 week period, while SPY has returned -1.5% and -1.3%, respectively.
VMD support price is $8.78 and resistance is $9.18 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that VMD shares will trade within this expected range on the day.
